Logo

Drug Discovery Enzymes Market Size, Share, Growth, and Regional Forecast, 2026 to 2033

Drug Discovery Enzymes Market by Product Type (Active Kinases, Ubiquitin Enzymes, Epigenetic Enzymes, Methyltransferases, and Others), by Application (Target Identification & Validation, High-Throughput Screening Assays, Lead Discovery & Optimization, Biocatalysis in Drug Synthesis, Biomarker Discovery & Diagnostics, and Personalized Medicine Development) by End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations (CROs), Diagnostic Laboratories, and Others), and Regional Analysis from 2026 to 2033

ID: PMRREP33955
Calendar

March 2026

215 Pages

Author : Pravin Rewale

Healthcare
  1. Executive Summary
    1. Global Drug Discovery Enzymes Market Snapshot, 2026 and 2033
    2. Market Opportunity Assessment, 2026 - 2033, US$ Bn
    3. Key Market Trends
    4. Future Market Projections
    5. Premium Market Insights
    6. Industry Developments and Key Market Events
    7. PMR Analysis and Recommendations
  2. Market Overview
    1. Market Scope and Definition
    2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Key Trends
    3. Macro-Economic Factors
      1. Global Sectorial Outlook
      2. Global GDP Growth Outlook
    4. COVID-19 Impact Analysis
    5. Forecast Factors - Relevance and Impact
  3. Value Added Insights
    1. Product Type Adoption Analysis
    2. Recent Product Type Launches
    3. Regulatory Landscape
    4. Value Chain Analysis
    5. Key Deals and Mergers
    6. PESTLE Analysis
    7. Porter’s Five Force Analysis
  4. Price Trend Analysis, 2020 - 2033
    1. Key Highlights
    2. Key Factors Impacting Product Type Prices
    3. Pricing Analysis, By Product Type Type
    4. Regional Prices and Product Type Preferences
  5. Global Drug Discovery Enzymes Market Outlook:
    1. Key Highlights
      1. Market Size (US$ Bn) and Y-o-Y Growth
      2. Absolute $ Opportunity
    2. Market Size (US$ Bn) Analysis and Forecast
      1. Historical Market Size (US$ Bn) Analysis, 2020-2025
      2. Market Size (US$ Bn) Analysis and Forecast, 2026-2033
    3. Global Drug Discovery Enzymes Market Outlook: Product Type
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis and Volume (Units) Analysis, By Product Type, 2020 - 2025
      3. Market Size (US$ Bn) Analysis and Volume (Units) Analysis and Forecast, By Product Type, 2026 - 2033
        1. Active Kinases
        2. Ubiquitin Enzymes
        3. Epigenetic Enzymes
        4. Methyltransferases
        5. Others
      4. Market Attractiveness Analysis: By Product Type
    4. Global Drug Discovery Enzymes Market Outlook: Application
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Application, 2020 - 2025
      3. Market Size (US$ Bn) Analysis and Forecast, By Application, 2026 - 2033
        1. Target Identification & Validation
        2. High-Throughput Screening Assays
        3. Lead Discovery & Optimization
        4. Biocatalysis in Drug Synthesis
        5. Biomarker Discovery & Diagnostics
        6. Personalized Medicine Development
      4. Market Attractiveness Analysis: By Application
    5. Global Drug Discovery Enzymes Market Outlook: End User
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By End User, 2020 - 2025
      3. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 - 2033
        1. Pharmaceutical & Biotechnology Companies
        2. Academic & Research Institutes
        3. Contract Research Organizations (CROs)
        4. Diagnostic Laboratories
        5. Others
      4. Market Attractiveness Analysis: End User
  6. Global Drug Discovery Enzymes Market Outlook: Region
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Region, 2020 - 2025
    3. Market Size (US$ Bn) Analysis and Forecast, By Region, 2026 - 2033
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
    4. Market Attractiveness Analysis: Region
  7. North America Drug Discovery Enzymes Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
      1. By Country
      2. By Product Type
      3. By Application
      4. By End User
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
      1. U.S.
      2. Canada
    4. Market Size (US$ Bn) Analysis and Volume (Units) Analysis and Forecast, By Product Type, 2026 - 2033
      1. Active Kinases
      2. Ubiquitin Enzymes
      3. Epigenetic Enzymes
      4. Methyltransferases
      5. Others
    5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2026 - 2033
      1. Target Identification & Validation
      2. High-Throughput Screening Assays
      3. Lead Discovery & Optimization
      4. Biocatalysis in Drug Synthesis
      5. Biomarker Discovery & Diagnostics
      6. Personalized Medicine Development
    6. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 - 2033
      1. Pharmaceutical & Biotechnology Companies
      2. Academic & Research Institutes
      3. Contract Research Organizations (CROs)
      4. Diagnostic Laboratories
      5. Others
    7. Market Attractiveness Analysis
  8. Europe Drug Discovery Enzymes Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
      1. By Country
      2. By Product Type
      3. By Application
      4. By End User
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Rest of Europe
    4. Market Size (US$ Bn) Analysis and Volume (Units) Analysis and Forecast, By Product Type, 2026 - 2033
      1. Active Kinases
      2. Ubiquitin Enzymes
      3. Epigenetic Enzymes
      4. Methyltransferases
      5. Others
    5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2026 - 2033
      1. Target Identification & Validation
      2. High-Throughput Screening Assays
      3. Lead Discovery & Optimization
      4. Biocatalysis in Drug Synthesis
      5. Biomarker Discovery & Diagnostics
      6. Personalized Medicine Development
    6. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 - 2033
      1. Pharmaceutical & Biotechnology Companies
      2. Academic & Research Institutes
      3. Contract Research Organizations (CROs)
      4. Diagnostic Laboratories
      5. Others
    7. Market Attractiveness Analysis
  9. East Asia Drug Discovery Enzymes Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
      1. By Country
      2. By Product Type
      3. By Application
      4. By End User
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
      1. China
      2. Japan
      3. South Korea
    4. Market Size (US$ Bn) Analysis and Volume (Units) Analysis and Forecast, By Product Type, 2026 - 2033
      1. Active Kinases
      2. Ubiquitin Enzymes
      3. Epigenetic Enzymes
      4. Methyltransferases
      5. Others
    5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2026 - 2033
      1. Target Identification & Validation
      2. High-Throughput Screening Assays
      3. Lead Discovery & Optimization
      4. Biocatalysis in Drug Synthesis
      5. Biomarker Discovery & Diagnostics
      6. Personalized Medicine Development
    6. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 - 2033
      1. Pharmaceutical & Biotechnology Companies
      2. Academic & Research Institutes
      3. Contract Research Organizations (CROs)
      4. Diagnostic Laboratories
      5. Others
    7. Market Attractiveness Analysis
  10. South Asia & Oceania Drug Discovery Enzymes Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
      1. By Country
      2. By Product Type
      3. By Application
      4. By End User
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of South Asia & Oceania
    4. Market Size (US$ Bn) Analysis and Volume (Units) Analysis and Forecast, By Product Type, 2026 - 2033
      1. Active Kinases
      2. Ubiquitin Enzymes
      3. Epigenetic Enzymes
      4. Methyltransferases
      5. Others
    5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2026 - 2033
      1. Target Identification & Validation
      2. High-Throughput Screening Assays
      3. Lead Discovery & Optimization
      4. Biocatalysis in Drug Synthesis
      5. Biomarker Discovery & Diagnostics
      6. Personalized Medicine Development
    6. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 - 2033
      1. Pharmaceutical & Biotechnology Companies
      2. Academic & Research Institutes
      3. Contract Research Organizations (CROs)
      4. Diagnostic Laboratories
      5. Others
    7. Market Attractiveness Analysis
  11. Latin America Drug Discovery Enzymes Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
      1. By Country
      2. By Product Type
      3. By Application
      4. By End User
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
      1. Brazil
      2. Mexico
      3. Rest of Latin America
    4. Market Size (US$ Bn) Analysis and Volume (Units) Analysis and Forecast, By Product Type, 2026 - 2033
      1. Active Kinases
      2. Ubiquitin Enzymes
      3. Epigenetic Enzymes
      4. Methyltransferases
      5. Others
    5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2026 - 2033
      1. Target Identification & Validation
      2. High-Throughput Screening Assays
      3. Lead Discovery & Optimization
      4. Biocatalysis in Drug Synthesis
      5. Biomarker Discovery & Diagnostics
      6. Personalized Medicine Development
    6. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 - 2033
      1. Pharmaceutical & Biotechnology Companies
      2. Academic & Research Institutes
      3. Contract Research Organizations (CROs)
      4. Diagnostic Laboratories
      5. Others
    7. Market Attractiveness Analysis
  12. Middle East & Africa Drug Discovery Enzymes Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
      1. By Country
      2. By Product Type
      3. By Application
      4. By End User
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
      1. GCC Countries
      2. Egypt
      3. South Africa
      4. Northern Africa
      5. Rest of Middle East & Africa
    4. Market Size (US$ Bn) Analysis and Volume (Units) Analysis and Forecast, By Product Type, 2026 - 2033
      1. Active Kinases
      2. Ubiquitin Enzymes
      3. Epigenetic Enzymes
      4. Methyltransferases
      5. Others
    5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2026 - 2033
      1. Target Identification & Validation
      2. High-Throughput Screening Assays
      3. Lead Discovery & Optimization
      4. Biocatalysis in Drug Synthesis
      5. Biomarker Discovery & Diagnostics
      6. Personalized Medicine Development
    6. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 - 2033
      1. Pharmaceutical & Biotechnology Companies
      2. Academic & Research Institutes
      3. Contract Research Organizations (CROs)
      4. Diagnostic Laboratories
      5. Others
    7. Market Attractiveness Analysis
  13. Competition Landscape
    1. Market Structure
      1. Competition Intensity Mapping By Market
      2. Competition Dashboard
    2. Company Profiles (Details - Overview, Recent Developments)
      1. Sigma-Aldrich Co. LLC.
        1. Overview
        2. Segments and Product Type & End User
        3. Key Financials
        4. Market Developments
        5. Market Strategy
      2. Kaneka Corporation
      3. Actelion Pharmaceuticals Ltd
      4. Genesis Biotechnology Group
      5. Suven Life Sciences Limited
      6. Enzo Life Sciences, Inc.
      7. Merck KGaA
      8. Apeiron Biologics AG
      9. STORM Therapeutics Limited
      10. Thermo Fisher Scientific Inc.
      11. Abcam plc
      12. Promega Corporation
      13. BPS Bioscience, Inc.
      14. Takara Bio Inc.
      15. New England Biolabs, Inc.
      16. Others
  14. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations
Emailsales@persistencemarketresearch.com
UK

Corporate Office

Persistence Research & Consultancy Services Limited

Company Number : 15310893

Second Floor, 150 Fleet Street,London, EC4A 2DQ.

+44 203-837-5656
USA

Regional Office

Persistence Market Research

108 W 39th Street, Ste 1006,PMB2219, New York, NY 10018

+1 646-878-6329
India

Global Research centre

Persistence Market Research Private Limited

CIN : U74900PN2014PTC153163

IT Unit No. 504, 5th Floor, IconTower, Baner, Pune - 411045.

+91 906 779 3500SIN : +65 6531 3894 98
Quick Links
CareersTerms & ConditionsReturn PolicyMarket Research Report
Customer FAQ’sPrivacy PolicySitemap

Copyright © 2026 Persistence Market Research. All Rights Reserved

Connect With Us -